BioCryst Pharmaceuticals
BCRX
#4817
Rank
$1.52 B
Marketcap
$7.38
Share price
1.03%
Change (1 day)
36.57%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - P/B ratio

P/B ratio as of November 2024 : -3.23

According to BioCryst Pharmaceuticals 's latest financial reports the company has a price-to-book ratio of 3.95586.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

BioCryst Pharmaceuticals - P/B ratio (from 2001 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-31-2.69-62.93%
2022-12-31-7.26-68.81%
2021-12-31-23.3-65.89%
2020-12-31-68.3-591.41%
2019-12-3113.9-22.97%
2018-12-3118.0212.76%
2017-12-315.77-98.05%
2016-12-312961765.24%
2015-12-3115.937.12%
2014-12-3111.6-102.9%
2013-12-31-399150.56%
2012-12-31-159-2210.4%
2011-12-317.54112.56%
2010-12-313.557.92%
2009-12-313.29191.24%
2008-12-311.13-68.77%
2007-12-313.62-77.38%
2006-12-3116.093.53%
2005-12-318.2692.63%
2004-12-314.29-0.37%
2003-12-314.30918.74%
2002-12-310.4224

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
3.92-221.40%๐Ÿ‡บ๐Ÿ‡ธ USA
8.67-368.73%๐Ÿ‡บ๐Ÿ‡ธ USA
1.66-151.58%๐Ÿ‡บ๐Ÿ‡ธ USA
-2.99-7.32%๐Ÿ‡บ๐Ÿ‡ธ USA
6.07-288.10%๐Ÿ‡บ๐Ÿ‡ธ USA
2.23-169.06%๐Ÿ‡บ๐Ÿ‡ธ USA
3.78-217.11%๐Ÿ‡ฌ๐Ÿ‡ง UK
1.25-138.60%๐Ÿ‡บ๐Ÿ‡ธ USA
4.73-246.55%๐Ÿ‡บ๐Ÿ‡ธ USA